Metabolic
Credibility 80
Association of GLP-1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program.
June 18, 2026 · Diabetes, obesity & metabolism
Key takeaway
For our community, this study found that Black adults with type 2 diabetes who took GLP-1 medicines had fewer serious liver problems. This means these medicines might offer better protection for our livers.
Why this matters for our communities
Research in metabolic helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Metabolic
December 31, 2026"Sometimes it's the bullying": an exploratory qualitative study of church leaders' perceptions of dietary health of black American children and youth.Read December 31, 2026What unhealthy food and beverage advertisements appeal to- and promote obesity amongst- adolescent children in urban South Africa?Read December 6, 2026Program and Family Predictors of Retention and Weight Loss Among Black Youth in a Pediatric Weight Management Program.Read